HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

3,5-Dihydroxy-2-(3-oxooctyl)cyclopentanepropanoic acid, (1R,2R,3R,5S)-

HCID 168168
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
24379-94-0
Standard SMILES
CCCCCC(=O)CC[C@@H]1[C@@H](CCC(=O)O)[C@@H](O)C[C@H]1O
InChIKey
UIZLUZTVNFGFMX-TUVASFSCSA-N
Molecular formula
C16H28O5
Average molar mass
300.39 g/mol
Monoisotopic mass
300.19367399

Overview

main urinary PGF2alpha metabolite in guinea pigs; RN given for (1R-(1alpha,2beta,3alpha,5alpha))-isomer

Names & identifiers

Preferred name
3,5-Dihydroxy-2-(3-oxooctyl)cyclopentanepropanoic acid, (1R,2R,3R,5S)-
IUPAC
3-[(1R,2R,3R,5S)-3,5-dihydroxy-2-(3-oxooctyl)cyclopentyl]propanoic acid
English name
5,7-dihydroxy-11-ketotetranorprostanoic acid
Molecular formula
C16H28O5
Molecular weight
300.39

Names & synonyms

24379-94-05,7-Dihydroxy-11-ketotetranorprostanoic acidGP-Pgf mum11-Ketotetranor pgf metabolite, guinea pig82S34F210R3,5-DIHYDROXY-2-(3-OXOOCTYL)CYCLOPENTANEPROPANOIC ACID, (1R,2R,3R,5S)-Cyclopentanepropanoic acid, 3,5-dihydroxy-2-(3-oxooctyl)-, (1R-(1alpha,2beta,3alpha,5alpha))-RefChem:1013393-[(1r,2r,3r,5s)-3,5-dihydroxy-2-(3-oxooctyl)cyclopentyl]propanoic acid13,14-Dihydro-15-keto-tetranor prostaglandin F1alpha5,7-Dihydroxy-11-oxotetranorprostanoic acid3-((1R,2R,3R,5S)-3,5-Dihydroxy-2-(3-oxooctyl)cyclopentyl)propanoic acid
Show more names
UIZLUZTVNFGFMX-TUVASFSCSA-N13,14-dihydro-15-keto-tetranor Prostaglandin F1α13,14-dihydro-15-keto-tetranor Prostaglandin F1.alpha.13,14-dihydro-15-keto-tetranor Prostaglandin F1α ExclusiveCyclopentanepropanoic acid, 3,5-dihydroxy-2-(3-oxooctyl)-, (1R,2R,3R,5S)-
UNII-82S34F210RFA 16:2;O3DTXSID70947236LMFA03010305PD021198HY-114687CS-006409115-oxo-13,14-dihydro-2,3,4,5-tetranor-PGF2alpha

Properties

Computed structural propertiesFilling in

XLogP
1.4
Topological polar surface area
94.8 Ų
Hydrogen bond donors
3
Hydrogen bond acceptors
5
Rotatable bonds
10
Heavy atoms
21
Formal charge
0
Complexity
342

Experimental & physicochemical properties

LipidsFatty Acyls [FA] -> Eicosanoids [FA03] -> Prostaglandins [FA0301]

Physicochemical properties

solubility
50 mg/ml; · DMF: 50 mg/ml; DMSO: 50 mg/ml; Ethanol: 50 mg/ml; PBS (pH 7.2): 1 mg/ml
FDA UNII
82 S34F210R · 82S34F210R
Symbol(GHS)
2 · GHS02
Signal word
Danger
Hazard statements
225 · H225
Precautionary statements
210 · P210-P233-P240-P241-P242-P243-P280-P303+P361+P353-P370+P378-P403+P235-P501

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Safety data

Signal word
Danger
Symbol(GHS)
GHS02
Hazard statements
H225
Precautionary statements
P210-P233-P240-P241-P242-P243-P280-P303+P361+P353-P370+P378-P403+P235-P501

Chemistry & industry

Applications

Uses5,7-Dihydroxy-11-ketotetranorprostanoic acid is a urinary metabolite of prostaglandin F2α and precursor to tetranor-PGF metabolites, exhibits hardly activity in blood pressure assay and smooth muscle stiumulation assay[1].

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes

Database identifiers

CAS
24379-94-0
PubChem CID
168168
DTXSID
DTXSID70947236
UNII
82S34F210R
Nikkaji
J88.255K